National Biotech Reporter The Food and Drug Administration has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for compounding pharmacies to make copies. Novo’s semaglutide, sold under the brand names Ozempic for diabetes and...
s semaglutide, marketed as Wegovy for people with obesity andOzempicfor those with Type 2 diabetes, has been on theFDA Drug Shortageslist since August 2022. Novo Nordisk’sliraglutide, indicated for weight loss as Saxenda and for Type 2 diabetes asVictoza, has been on the list...
SILVER SPRING, Md.,Dec. 6, 2024/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA published the draft guidance, "Expedited Program for Serious Conditions — Accelerated Approval of Drugs an...
The FDA announced a similar policy for pharmacies making tirzepatide compounds when that shortage was resolved in December. In August, drug manufacturer Eli Lilly began sending cease-and-desist letters to telehealth companies, wellness centers and medical spas selling compounded versions of Zepbound an...
The Minnesota Department of Health has put out a health advisory warning of an impending shortage in Bicillin, used primarily for treating syphilis. Aug 8, 2023 Researchers say another Alzheimer's drug slows disease by a few months Eli Lilly's experimental Alzheimer's drug donanemab can ...
Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today the FDA released a Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. The strategy builds on the Immediate National Strategy to Increase the Resiliency...
The Drug Enforcement Administration on Wednesday issued an announcement 16 years in the making: it will create a special registration process for prescribers wishing to provide controlled substances, like opioids or stimulants used to treat ADHD, via telemedicine. ...
The agency on Thursday said that, for the first time since the outbreak, a drugmaker reported a coronavirus-related shortage for an undisclosed drug because it can't access enough raw components, which are made in China. The FDA did not name the drug, the condition it treats or the manufa...
The device shortage list does not include IV bags,domestic production of which was disrupted by Hurricanes Helene and Milton. However, the agency added Dextrose 70% IV solution, Lactated Ringers IV Solution, and Peritoneal Dialysis Solution to itsDrug Shortages Database, saying it considers thos...
Food and Drug Administration announced it will allow Abbott to resume producing certain baby formula products on a case-by-case basis after a massive safety recall earlier this year. The announcement comes as many parents scramble to find baby formula because the recall and supply disruptions ...